Approximately 1 in 4 first prescriptions for oral pre-exposure prophylaxis (PrEP) for HIV prevention are not dispensed within 14 days, according to a national study of more than 140,000 such prescriptions by researchers at Gilead Sciences, Walgreens and Emory University.
“First prescriptions are a really important aspect with PrEP,” said study co-author Dylan Mezzio, PharmD, a director within the Global Value and Access-Health Economics and Outcomes Research team at